Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | NOS3 | P29474 | 4/20 | 0.45 |
| ▸ | NOS1 | P29475 | 4/20 | 0.45 |
| ▸ | NOS2 | P35228 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.38 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.37 |
| ▸ | KLK1 | P06870 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17897095 | 0.91 | MEN1 (0.52) | MEN1KMT2ANOS3NOS1ATM | |
| SCHEMBL17897084 | 0.87 | MEN1 (0.48) | MEN1KMT2ANOS3NOS1ATM | |
| SCHEMBL17897170 | 0.83 | MEN1 (0.44) | MEN1KMT2ANOS3NOS1ATM | |
| SCHEMBL19234342 | 0.83 | MEN1 (0.44) | MEN1KMT2ANOS3NOS1ATM | |
| SCHEMBL17897097 | 0.83 | MEN1 (0.44) | MEN1KMT2ANOS3NOS1ATM | |
| SCHEMBL15161153 | 0.83 | AR (0.41) | MEN1KMT2ANOS3NOS1NOS2 | |
| SCHEMBL15159295 | 0.77 | KDM4E (0.42) | MEN1KMT2AATMKDM4EALDH1A1 | |
| SCHEMBL12517905 | 0.75 | KDM4E (0.44) | MEN1KMT2AKDM4EALDH1A1HSD17B10 | |
| SCHEMBL15159296 | 0.72 | AR (0.41) | MEN1KMT2AATMMETAP2KDM4E | |
| SCHEMBL15161179 | 0.72 | ALDH1A1 (0.48) | MEN1KMT2AKDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9732378-B2 | Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-08-15 | — | — | US | disclosed |
| US-20160194690-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160194690-A1 | FLUOROPHORE CHELATED LANTHANIDE LUMINESCENT PROBES WITH IMPROVED QUANTUM EFFICIENCY | CLTA, LARS1, SSB | MEN1 1163/4885KMT2A 3287/4885NOS3 3392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.